Consider the following medical report that includes the patient's historical health records. Use it to predict the disease that the patient is high likely exposed to. 

 Medical Report: allergies: patient recorded as having no known allergies to drugs attending: chief complaint: shoulder pain major surgical or invasive procedure: cardiac catheterization avr ( 21mm st. porcine)/ cabg x3 (lima to lad, svg to om, svg to rca) history of present illness: 79m w/ cad, as, dm, htn, hyperlipidemia p/w acute onset bilateral shoulder pain occuring at rest, radiating down the arms, associated w/ sob and mild diaphoresis. notably, the patient has had subacute crescendo angina over the course of weeks to months refractory to sl nitro, prompting use of a nitro patch at night. he sleeps sitting upright in a chair due to orthopnea. he notes intermittent le swelling. he has had a week h/o uri symptoms, dry cough, and occasional chills. the patient's wife notes that he had loc and a fall 1 month ago. he has not had fever, abdominal pain, or n/v/d. he has not had sick contacts or recent travel. he presented to - where bp 144/75 hr 79 rr 20 o2sat 95% ra. ekg showed diffuse 2- depressions. he was given plavix 600 mg, heparin gtt, and nitro gtt prior to transfer to . in our ed, t 98.8 hr 71 bp 118/56 rr 22 o2sat 99% ra. ekg showed resolution of std in ii,iii,f (c/ ekg), <1 mm ste in v1-v2, and persistent >1 mm std in v4-v5. he was started on nitro gtt for persistent cp and heparin gtt, which was d/c'd when noted to be guaiac positive. he was transferred to the floor for further evaluation. he is currently pain-free off nitro. ruled in for nstemi. past medical history: cad dchf (ef 55-60% tte) as ( 1.0 cm2 tte) dmii htn hyperlipidemia prostate ca s/p prostatectomy social history: lives with wife in , ma. retired salesman. former 3 pack/day smoker, quit >30 years ago. currently smokes a pipe. drinks 2-4 etoh 2-3x/week. family history: mother had cva. father had bladder ca. no known h/o premature cad. physical exam: admission physical exam 5'8" 190# v/s - t 97.5 hr 68 bp 122/64 rr 18 o2sat 99% 2l. gen: elderly obese male lying flat in bed, nad heent: nc/at, sclera anicteric, perrl, eomi, op clear with dry mm neck: supple, jvp difficult to assess due to habitus cv: rrr nl s1s2 iii/vi sem @ lusb no r/g pulm: l basilar crackles no wheeze/rhonchi abd: soft obese ntnd normoactive bs ext: warm, dry w/ 1+ pt/dp pulses, 1+ symmetrical pitting le edema pertinent results: @ 0856 - sr @ 70 bpm, lad, <1 mm ste r, <1 mm std ii,f,v3, <2 mm std v4-v5; qtc 453 ms echo: pre-cpb: the left atrium and right atrium are normal in cavity size. no mass/thrombus is seen in the left atrium or left atrial appendage. left ventricular wall thicknesses are normal. the left ventricular cavity size is normal. no left ventricular aneurysm is seen. there is moderate regional left ventricular systolic dysfunction with lvef approximately 30-35%. . no masses or thrombi are seen in the left ventricle. the remaining left ventricular segments contract normally. right ventricular chamber size and free wall motion are normal. there are simple atheroma in the aortic arch. there are simple atheroma in the descending thoracic aorta. the aortic valve leaflets are severely thickened/deformed. there is severe aortic stenosis. (~ 0.8-0.9 cm2) trace aortic regurgitation is seen. the aortic regurgitation jet is eccentric. the mitral valve leaflets are structurally normal. mild (1+) mitral regurgitation is seen. there is no pericardial effusion. postbypass: the pt is receiving an infusion of milrinone at 0.15 uck/kg/min and norepinephrine at 0.08 ucg/kg/min. there is preserved rv systolic. lv systolic function is mildly improved in the setting of inotropes (walls that contact well prebypass are more hyperdynamic/walls that were hypokinetic remain hypokinetic) there is a well seated bioprosthesis in the aortic position. there is a perivalvular ai jet originating in the area outside and between the left and right coronary cusps of the prosthesis. the ai is moderate (2+) in quantity. the remaining study is unchanged from prebypass. cath: 1. selective coronary angiography of this right dominant system demonstrated 3-vessel disease. the lmca is short and heavily calcified. the lad is totally occluded proximally. there is collateral flow from left to left and right to left. the lcx is non-dominant with a discrete 90% om2 lesion. the rca is a dominant vessel with an 80% lesion at the origin and is heavily calcified. there are robust right to left collaterals. 2. resting hemodynamics revealed a systolic arterial blood pressure of 133/62 mmhg. 02:16am blood wbc-14.5* rbc-3.55* hgb-11.0* hct-33.2* mcv-94 mch-30.9 mchc-32.9 rdw-16.0* plt ct-334 02:10am blood pt-13.5* ptt-32.1 inr(pt)-1.2* 11:50am blood glucose-183* urean-27* creat-1.0 na-141 k-3.7 cl-105 , m 79 radiology report chest (portable ap) study date of 7:12 am , csru sched chest (portable ap) clip # reason: evaluate effusions medical condition: 79 year old man with s/p cabg reason for this examination: evaluate effusions final report single view of the chest history: 79-year-old man, status post cabg; evaluate effusions. findings: single bedside ap examination labeled "supine at 7:25 a.m." is compared with upright studies obtained the preceding day. the patient is status post recent cabg with midline surgical staples in situ and intact sternal cerclage wires. allowing for the positioning, the overall appearance is not much changed. there is persistent lv enlargement without vascular congestion and only small bilateral pleural effusions. there is right more than left basilar subsegmental atelectasis, with no other airspace process. atherosclerotic calcification of the thoracic aorta is redemonstrated. impression: status post recent cabg without chf or significant effusion. dr. approved: fri 2:12 pm brief hospital course: as mentioned in the hpi, mr. presented to an osh with a nstemi. he was medically managed and transferred to for further care. on he underwent a cardiac cath which revealed three vessel coronary artery disease and aortic stenosis. on he was brought to the operating room where he underwent a coronary artery bypass graft and aortic valve replacement. please see operative report for surgical details. following surgery he was transferred to the cvicu for invasive monitoring in stable condition. remained on levophed, milrinone, and vasopressin drips which were slowly weaned over a few days. within 25 hours he was weaned from sedation, awoke neurologically intact and extubated. on post-op day four chest tubes were removed. bedside swallowing eval. performed on post-op day five as he had some dysphagia with emesis along with altered mental status. he slowly developed worsening pulmonary edema despite aggressively pulmonary toilet. he required a right thoracentesis for an effusion on post-op day twelve. he also had thoracentesis on the left and his respiratory status improved. he was intermittently on bipap at night and no longer requires this. his mental status and respiratory status improved and he was discharged to rehab in stable condition on pod#15. medications on admission: asa 325 mg daily, plavix 75 mg daily, atenolol 25 mg daily, isosorbide 30 mg qam, norvasc 1.25 mg qpm, lasix 60 mg daily, metformin 500 , lipitor 80 mg daily, klor-con 20 meq , nitro patch 0.4 mg/hr, oscal 600+ bida, mvi discharge medications: 1. aspirin 81 mg tablet, delayed release (e.c.) sig: one (1) tablet, delayed release (e.c.) po daily (daily). disp:*30 tablet, delayed release (e.c.)(s)* refills:*2* 2. acetaminophen 325 mg tablet sig: two (2) tablet po q4h (every 4 hours) as needed for temperature >38.0. 3. docusate sodium 100 mg capsule sig: one (1) capsule po bid (2 times a day). 4. albuterol sulfate 2.5 mg /3 ml (0.083 %) solution for nebulization sig: one (1) inhalation q4h (every 4 hours) as needed. 5. ipratropium bromide 0.02 % solution sig: one (1) inhalation q6h (every 6 hours) as needed. 6. folic acid 1 mg tablet sig: one (1) tablet po daily (daily). 7. thiamine hcl 100 mg tablet sig: one (1) tablet po daily (daily). 8. atorvastatin 80 mg tablet sig: one (1) tablet po daily (daily). 9. magnesium hydroxide 400 mg/5 ml suspension sig: thirty (30) ml po q6h (every 6 hours) as needed. 10. potassium chloride 20 meq tab sust.rel. particle/crystal sig: one (1) tab sust.rel. particle/crystal po prn (as needed) as needed for k<4.0. 11. atenolol 25 mg tablet sig: 0.5 tablet po daily (daily). 12. furosemide 20 mg tablet sig: one (1) tablet po bid (2 times a day). 13. bisacodyl 10 mg suppository sig: one (1) suppository rectal daily (daily) as needed. 14. insulin glargine 100 unit/ml solution sig: twenty five (25) units subcutaneous once a day. 15. insulin lispro 100 unit/ml solution sig: various subcutaneous four times a day: ss. 16. fosamax 70 mg tablet sig: one (1) tablet po once a week. 17. metformin 500 mg tablet sig: one (1) tablet po twice a day. discharge disposition: extended care facility: - discharge diagnosis: aortic stenosis s/p aortic valve replacement cad s/p coronary artery bypass graft x 3 pmh: hypercholesterolemia, etoh abuse, h/o prostate ca, s/p prostatectomy, niddm, htn discharge condition: good discharge instructions: no lifting more than 10 pounds for 10 weeks shower daily,no baths or swimming no creams, lotions or powders to incisions no driving for 4 weeks and off narcotics take all prescribed medications as directed report any wound drainage/redness or fever greater than 101 to our office. followup instructions: followup with dr. in 4 weeks () followup with dr. in 2 weeks see dr. in weeks procedure: venous catheterization, not elsewhere classified single internal mammary-coronary artery bypass extracorporeal circulation auxiliary to open heart surgery coronary arteriography using two catheters (aorto)coronary bypass of two coronary arteries intraoperative cardiac pacemaker left heart cardiac catheterization diagnostic ultrasound of heart thoracentesis thoracentesis open and other replacement of aortic valve arterial catheterization arterial catheterization transfusion of other serum transfusion of platelets diagnoses: other iatrogenic hypotension subendocardial infarction, initial episode of care anemia, unspecified coronary atherosclerosis of native coronary artery unspecified pleural effusion congestive heart failure, unspecified unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled atherosclerosis of aorta personal history of malignant neoplasm of prostate aortic valve disorders alcohol abuse, unspecified other and unspecified hyperlipidemia other postprocedural status nonspecific abnormal findings in stool contents hyperosmolality and/or hypernatremia delirium due to conditions classified elsewhere oliguria and anuria orthopnea dysphagia, unspecified chronic combined systolic and diastolic heart failure 

Answer: The patient is high likely exposed to